News
Healthleap Secures $38M to Revolutionize Hospital Patient Screening with AI
FundingOctober 12, 2026, 3:36 am
Healthleap secured $38 million to advance its AI platform. This system flags undiagnosed conditions in hospital patients, starting with malnutrition. It reads EHRs daily, identifies high-risk individuals, and streamlines clinical workflows. Hospitals gain efficiency, improved patient outcomes, and significant financial returns by catching overlooked conditions early. The company expands its focus beyond malnutrition, aiming to cover over 40 major conditions, enhancing patient safety and reducing healthcare costs across the board. This innovation targets critical care gaps, transforming inpatient care by leveraging advanced artificial intelligence for proactive health management.
Hospitals confront a silent crisis. Undiagnosed conditions plague countless patients. Malnutrition is a prime example. Up to half of all hospitalized patients risk malnourishment. Less than nine percent receive a formal diagnosis. This gap leads to longer hospital stays. It causes worse patient outcomes. Millions of dollars in added costs follow. Healthcare systems struggle to catch these hidden threats. Busy clinical teams often miss crucial indicators.
Healthleap offers a powerful solution. The company developed an AI-powered clinical screening platform. This system aims to find these undetected conditions. It recently secured $38 million in combined seed and Series A funding. The financing fuels its expansion. An $8 million seed round saw co-leadership from Sequoia Capital and First Round Capital. Hummingbird Ventures led the $30 million Series A round. This significant investment highlights investor confidence.
The Healthleap platform integrates with existing electronic health record (EHR) systems. It analyzes patient data daily. The AI reviews notes, lab results, vital signs, medications, and diagnoses. It scrutinizes other patient data points. The system identifies signs indicating a patient needs a closer look. It does not diagnose patients directly. Instead, it assigns risk scores. These scores route into established hospital workflows. Clinicians then decide the next steps. This process ensures timely intervention.
Healthleap's journey began with malnutrition. Co-founder Jemima Meyer, a clinical dietitian, first developed a tool. This early system helped dietitians identify at-risk patients sooner. She later joined forces with her brother, Josiah Meyer. They founded Healthleap in 2022. What started as a focused nutrition tool evolved. It became a broader clinical AI platform. The company's origins in addressing a specific, critical need underline its practical approach.
The platform provides continuous multi-source chart ingestion. It reads each patient’s complete EHR every morning. This includes physician progress notes, nursing assessments, laboratory panels, vital trajectories, active medication orders, and historical problem lists. It synthesizes this vast amount of data. This comprehensive daily review replaces static, manual screening methods. Traditional hospital protocols often miss at-risk patients. For example, a single two-question survey upon admission often fails. It overlooks sedated, confused, or critically ill individuals. Healthleap's dynamic approach overcomes these limitations.
Healthleap's measurable results validate its technology. At the Hospital of the University of Pennsylvania, its malnutrition program generated substantial financial impact. The reported annualized figure reached $23.8 million. This included $6.3 million in additional reimbursement. An estimated $17.5 million came from shorter hospital stays. This represented 8,632 annualized bed-days saved. Penn Medicine’s Strategic Decision Support team reviewed this analysis.
Similar success emerged at Cedars-Sinai. The company reported a 39% increase in malnutrition diagnoses. This occurred without increasing staffing levels. It translated to an $11 million annual financial impact. These results demonstrate both clinical efficacy and significant financial returns for healthcare systems. The financial benefits stem partly from Medicare Severity Diagnosis Related Group (MS-DRG) payment methodologies. Severe malnutrition qualifies as a major complication or comorbidity (MCC). Accurate identification allows hospitals to capture approximately $11,000 in incremental reimbursement per qualified encounter. It also reduces avoidable inpatient days.
Clinical research supports Healthleap's core malnutrition model. A peer-reviewed study evaluated its effectiveness. Published in *Applied Clinical Informatics*, it analyzed over 166,000 hospital admissions. The study spanned 3.75 years. The system showed 88% higher sensitivity than a modified Malnutrition Screening Tool. It identified patients an average of four days before initial dietitian documentation. This early detection capability is crucial for improving patient outcomes.
Healthleap has experienced rapid growth. It expanded from three hospital partners to over 50 in the past year. Revenue increased more than tenfold during this period. Key customers include Penn Medicine, Cedars-Sinai, Houston Methodist, Emory Healthcare, and Intermountain. This rapid adoption signals a strong demand for its innovative solution. Hospitals recognize the value of proactive patient identification.
The company's vision extends beyond malnutrition. It develops screening programs for additional high-cost acute inpatient conditions. These include delirium, aspiration pneumonia, pressure injuries, and congestive heart failure readmission risk. The longer-term goal targets covering over 40 major conditions. Healthleap eventually plans to extend its system beyond hospitals. Outpatient and home care settings represent future expansion areas. This multi-condition roadmap promises broad impact on patient health.
The newly secured funding will fuel various strategic initiatives. It will support engineering and product development. Sales and customer success teams will also benefit. Investing in these areas ensures continued innovation. It supports broader market reach. It also guarantees robust support for existing and future hospital partners. The platform operates under full HIPAA compliance. It maintains SOC 2 certification. These standards ensure data security and privacy.
Healthleap's approach harnesses AI for a critical, yet straightforward task. It continuously reads patient records. Human clinicians rarely have time for such exhaustive daily review. The AI then points clinicians to patients most likely overlooked. This function acts as a powerful preventative tool. Catching conditions early prevents patients from getting sicker. It shortens hospital stays. Hospitals receive appropriate payment for care delivered. Payers avoid the much higher costs of complications. This creates a win for all stakeholders. Patients receive timely treatment. Healthcare costs decrease. Patient lives are saved. Healthleap aims to transform inpatient care through intelligent, proactive surveillance.
Hospitals confront a silent crisis. Undiagnosed conditions plague countless patients. Malnutrition is a prime example. Up to half of all hospitalized patients risk malnourishment. Less than nine percent receive a formal diagnosis. This gap leads to longer hospital stays. It causes worse patient outcomes. Millions of dollars in added costs follow. Healthcare systems struggle to catch these hidden threats. Busy clinical teams often miss crucial indicators.
Healthleap offers a powerful solution. The company developed an AI-powered clinical screening platform. This system aims to find these undetected conditions. It recently secured $38 million in combined seed and Series A funding. The financing fuels its expansion. An $8 million seed round saw co-leadership from Sequoia Capital and First Round Capital. Hummingbird Ventures led the $30 million Series A round. This significant investment highlights investor confidence.
The Healthleap platform integrates with existing electronic health record (EHR) systems. It analyzes patient data daily. The AI reviews notes, lab results, vital signs, medications, and diagnoses. It scrutinizes other patient data points. The system identifies signs indicating a patient needs a closer look. It does not diagnose patients directly. Instead, it assigns risk scores. These scores route into established hospital workflows. Clinicians then decide the next steps. This process ensures timely intervention.
Healthleap's journey began with malnutrition. Co-founder Jemima Meyer, a clinical dietitian, first developed a tool. This early system helped dietitians identify at-risk patients sooner. She later joined forces with her brother, Josiah Meyer. They founded Healthleap in 2022. What started as a focused nutrition tool evolved. It became a broader clinical AI platform. The company's origins in addressing a specific, critical need underline its practical approach.
The platform provides continuous multi-source chart ingestion. It reads each patient’s complete EHR every morning. This includes physician progress notes, nursing assessments, laboratory panels, vital trajectories, active medication orders, and historical problem lists. It synthesizes this vast amount of data. This comprehensive daily review replaces static, manual screening methods. Traditional hospital protocols often miss at-risk patients. For example, a single two-question survey upon admission often fails. It overlooks sedated, confused, or critically ill individuals. Healthleap's dynamic approach overcomes these limitations.
Healthleap's measurable results validate its technology. At the Hospital of the University of Pennsylvania, its malnutrition program generated substantial financial impact. The reported annualized figure reached $23.8 million. This included $6.3 million in additional reimbursement. An estimated $17.5 million came from shorter hospital stays. This represented 8,632 annualized bed-days saved. Penn Medicine’s Strategic Decision Support team reviewed this analysis.
Similar success emerged at Cedars-Sinai. The company reported a 39% increase in malnutrition diagnoses. This occurred without increasing staffing levels. It translated to an $11 million annual financial impact. These results demonstrate both clinical efficacy and significant financial returns for healthcare systems. The financial benefits stem partly from Medicare Severity Diagnosis Related Group (MS-DRG) payment methodologies. Severe malnutrition qualifies as a major complication or comorbidity (MCC). Accurate identification allows hospitals to capture approximately $11,000 in incremental reimbursement per qualified encounter. It also reduces avoidable inpatient days.
Clinical research supports Healthleap's core malnutrition model. A peer-reviewed study evaluated its effectiveness. Published in *Applied Clinical Informatics*, it analyzed over 166,000 hospital admissions. The study spanned 3.75 years. The system showed 88% higher sensitivity than a modified Malnutrition Screening Tool. It identified patients an average of four days before initial dietitian documentation. This early detection capability is crucial for improving patient outcomes.
Healthleap has experienced rapid growth. It expanded from three hospital partners to over 50 in the past year. Revenue increased more than tenfold during this period. Key customers include Penn Medicine, Cedars-Sinai, Houston Methodist, Emory Healthcare, and Intermountain. This rapid adoption signals a strong demand for its innovative solution. Hospitals recognize the value of proactive patient identification.
The company's vision extends beyond malnutrition. It develops screening programs for additional high-cost acute inpatient conditions. These include delirium, aspiration pneumonia, pressure injuries, and congestive heart failure readmission risk. The longer-term goal targets covering over 40 major conditions. Healthleap eventually plans to extend its system beyond hospitals. Outpatient and home care settings represent future expansion areas. This multi-condition roadmap promises broad impact on patient health.
The newly secured funding will fuel various strategic initiatives. It will support engineering and product development. Sales and customer success teams will also benefit. Investing in these areas ensures continued innovation. It supports broader market reach. It also guarantees robust support for existing and future hospital partners. The platform operates under full HIPAA compliance. It maintains SOC 2 certification. These standards ensure data security and privacy.
Healthleap's approach harnesses AI for a critical, yet straightforward task. It continuously reads patient records. Human clinicians rarely have time for such exhaustive daily review. The AI then points clinicians to patients most likely overlooked. This function acts as a powerful preventative tool. Catching conditions early prevents patients from getting sicker. It shortens hospital stays. Hospitals receive appropriate payment for care delivered. Payers avoid the much higher costs of complications. This creates a win for all stakeholders. Patients receive timely treatment. Healthcare costs decrease. Patient lives are saved. Healthleap aims to transform inpatient care through intelligent, proactive surveillance.